Skip to main content

Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Worldwide revenue of $406.8 million and $1.54 billion for the fourth quarter and full year 2025 GAAP fully diluted earnings per share of $0.82 and $3.41 for the fourth quarter and full year 2025 Adjusted fully diluted earnings per share of $1.67 and $6.08 for the fourth quarter and full year 2025 Repurchased $100 million of shares of common stock in the fourth quarter pursuant to the previously announced stock repurchase plan that was approved by the Board in July 2025 Company announced today that it is sharpening its strategic focus to innovative radiodiagnostics and pursuing value‑maximizing alternatives for radiotherapeutic assets to support long-term growth Company provides full year 2026 revenue and adjusted fully diluted earnings per share guidanceBEDFORD, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc....

Continue reading

Aclaris Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

– Positive Interim Results of Phase 1a Single (SAD) and Multiple Ascending Dose (MAD) Trial of Anti-TSLP/IL-4Rα Bispecific Antibody ATI-052 Support Rapid Clinical Advancement; Complete Top Line Results Expected in the Second Quarter of 2026 – – Phase 1b Proof-of-Concept Trials of ATI-052 in Atopic Dermatitis (AD) and Asthma Underway; Top Line Results from Both Trials Anticipated in the Second Half of 2026 – – Investigational New Drug (IND) Application for Lead ITK Inhibitor Candidate ATI-9494 Expected in the SecondHalf of 2026 – – ATI-2138, Aclaris’ Investigational Inhibitor of ITK and JAK3, Demonstrated Potential Best-in-Class Hair Regrowth in Murine Alopecia Model – WAYNE, Pa., Feb. 26, 2026 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS),...

Continue reading

Acme United Reports 12% Increase in Earnings per Share for the Fourth Quarter of 2025

SHELTON, Conn., Feb. 26, 2026 (GLOBE NEWSWIRE) — Acme United Corporation (NYSE American: ACU) today announced that net sales for the quarter ended December 31, 2025 were $47.5 million compared to $45.9 million in the fourth quarter of 2024, an increase of 3%. Net sales for the year ended December 31, 2025 were $196.5 million compared to $194.5 million in 2024, an increase of 1%. Net income was $1.9 million, or $0.46 per diluted share, for the quarter ended December 31, 2025 compared to $1.7 million, or $0.41 per diluted share, for the same period in 2024, an increase of 10% in net income and 12% in diluted earnings per share. Net income for the year ended December 31, 2025, was $10.2 million, or $2.49 per diluted share, compared to $10.0 million, or $2.45 per diluted share, for 2024, an increase of 2% in both net income and diluted...

Continue reading

Aveanna Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call

ATLANTA, Feb. 26, 2026 (GLOBE NEWSWIRE) — Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that the company will release its fourth quarter and full year results before the market open on Thursday, March 19, 2026, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day. The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available three hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13757396. The replay will be available until March 26, 2026. Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor...

Continue reading

Eos Energy Enterprises Reports Fourth Quarter and Full Year 2025 Financial Results; Delivers More than 7x Year-Over-Year Revenue Growth and Initiates 2026 Revenue Guidance

$58.0 million in record quarterly revenue with Q4 exceeding the first three 2025 quarters combined  Secured over $240 million with nearly 1.1 GWh of new orders in Q4 from eight customers spanning U.S. and international markets, highlighting diversified market demand Successfully executed a $600 million senior convertible notes issuance and registered direct common stock offering, ending the year with a record cash balance of $624.6 million Current liquidity and operational funding plan support ongoing operations and substantial doubt no longer exists about Company’s ability to continue as a going concern Launched Indensity™, a next-generation architecture built with Spatial Intelligence that targets up to 1 GWh per acre while delivering industry-leading flexibility and safety Initiates 2026 revenue guidance of $300 million to...

Continue reading

Gildan Reports Record Fourth Quarter Revenue and Adjusted Diluted EPS¹, Initiates Guidance for 2026, Provides Integration Update, Raises Targeted Run-Rate Synergies and Announces Plans to Build Bangladesh Phase 2

 (all amounts are in U.S. dollars except where otherwise indicated)(1) Please refer to “Definition and reconciliation of non-GAAP financial measures and related ratios” in this press release  Record fourth quarter net sales from continuing operations of $1,078 million, up 31.3% vs. the prior year, including HanesBrands’ contribution since December 1, 2025 Fourth quarter operating margin of 9.2%, adjusted operating margin1 of 20.7% Fourth quarter GAAP diluted EPS from continuing operations of $0.32, down 62.8% vs. the prior year, and record fourth quarter adjusted diluted EPS1 from continuing operations of $0.96, up 15.7% vs. the prior year Cash flow from operations of $336 million in Q4, up 59.8% vs. the prior year and $606 million for the full year, an increase of 20.9% vs. the prior year; free cash flow1...

Continue reading

TopBuild Reports Fourth Quarter and Year-End 2025 Results, Provides 2026 Outlook

Fourth Quarter HighlightsFourth quarter sales totaled $1.49 billion, up 13.2% driven by acquisitionsCompleted SPI Acquisition Full Year HighlightsCompleted seven acquisitions, adding approximately $1.2 billion in annual salesReturned $434.2 million in capital to stockholders through the repurchase of ~1.4 million shares 2026 OutlookExpects 2026 sales between $5.925 to $6.225 billion andadjusted EBITDA in the range of $1.005 billion to $1.155 billionAcquisitions continue to be top priority for deploying capital DAYTONA BEACH, Fla., Feb. 26, 2026 (GLOBE NEWSWIRE) — TopBuild Corp. (NYSE:BLD) a leading installer of insulation and commercial roofing and a specialty distributor of insulation and related building products to the construction industry in the United States and Canada, today reported results for the fourth quarter and year...

Continue reading

Playtika Holding Corp. Reports Q4 and 2025 Financial Results

Revenue of $678.8 million and Direct-to-Consumer (“DTC”) Revenue of $250.1 millionDTC Revenue Increased 19.5% Sequentially and 43.2% Year-Over-Year Net Loss of $(309.3) million, Adjusted Net Income of $89.0 million, and Adjusted EBITDA of $201.4 million HERZLIYA, Israel, Feb. 26, 2026 (GLOBE NEWSWIRE) — Playtika Holding Corp. (NASDAQ: PLTK) today released financial results for its fourth quarter and fiscal year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights:Revenue of $678.8 million increased 0.6% sequentially and 4.4% year-over-year. DTC platforms revenue of $250.1 million increased 19.5% sequentially and 43.2% year-over-year. Net loss of $(309.3) million and Adjusted net income of $89.0 million. Net loss reflects a non-cash impact from contingent consideration remeasurement related to the earnout payment...

Continue reading

Update: Enovis Announces Fourth Quarter and Full Year 2025 Results

Continued commercial momentum with full year 2025 sales growth of 7% on a reported basis and 6% organicallyFull year 2025 Reconstructive sales grew 10% Y/Y on a reported basis and 8% on an organic basisFull year 2025 Prevention & Recovery sales grew 4% Y/Y on a reported and organic basisDallas, TX, Feb. 26, 2026 (GLOBE NEWSWIRE) — Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the fourth quarter and full year ended December 31, 2025. The Company will host an investor conference call and live webcast to discuss these results today at 8:30 am ET. Fourth Quarter 2025 Financial Results Enovis’ fourth-quarter net sales of $576 million grew 3% on a reported basis and 2% on an organic basis from the same quarter in 2024. Fourth-quarter...

Continue reading

Neinor records €122mn FY25 Net Income after executing largest M&A in Spanish Residential of the last decade

MADRID, Feb. 26, 2026 (GLOBE NEWSWIRE) — Neinor Homes (“Neinor”) closed FY25 with standout operational and financial results. During FY25 and excluding the impact from acquiring a 79.2% stake in AEDAS, Neinor has notarized a total of 2,901 housing units, of which 1,891 corresponded to the fully owned portfolio and 1,010 to the Asset Management business. Total revenues for 2025 reached €697mn. Borja García-Egotxeaga, CEO of Neinor Homes, commented: “This was a transformational year for Neinor. We outperformed operationally, strengthened our balance sheet and closed the largest residential transaction in Spain in over a decade, creating the undisputed national champion. At a time when markets are being reshaped by AI and technological change, investors are seeking resilient, income-generating real assets. Spanish housing sits at...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.